Evaluation of Reference Tissue Models for the Analysis of [11C](R)-PK11195 Studies

[11C](R)-PK11195 is a marker of activated microglia, which can be used to measure inflammation in neurologic disorders. The purpose of the present study was to define the optimal reference tissue model based on a comparison with a validated plasma input model and using clinical studies and Monte Carlo simulations. Accuracy and reproducibility of reference tissue models were evaluated using Monte Carlo simulations. The effects of noise and variation in specific binding, nonspecific binding and blood volume were evaluated. Dynamic positron emission tomography scans were performed on 13 subjects, and radioactivity in arterial blood was monitored online. In addition, blood samples were taken to generate a metabolite corrected plasma input function. Both a (validated) two-tissue reversible compartment model with K1/k2 fixed to whole cortex and various reference tissue models were fitted to the data. Finally, a simplified reference tissue model (SRTM) corrected for nonspecific binding using plasma input data (SRTMpl_corr) was investigated. Correlations between reference tissue models (including SRTMpl_corr) and the plasma input model were calculated. Monte Carlo simulations indicated that low-specific binding results in decreased accuracy and reproducibility. In this respect, the SRTM and SRTMpl_corr performed relatively well. Varying blood volume had no effect on performance. In the clinical evaluation, SRTMpl_corr and SRTM had the highest correlations with the plasma input model (R2 = 0.82 and 0.78, respectively). SRTMpl_corr is optimal when an arterial plasma input curve is available. Simplified reference tissue model is the best alternative when no plasma input is available.

[1]  C Crouzel,et al.  PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  R. Frackowiak,et al.  Monitoring by PET of macrophage accumulation in brain after ischaemic stroke , 1992, The Lancet.

[3]  R. Myers,et al.  Quantitation of Carbon‐11‐labeled raclopride in rat striatum using positron emission tomography , 1992, Synapse.

[4]  N L Foster,et al.  PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Quantification of dopamine transporter studies using carbon-11 labelled RTI-121 and PET , 1995 .

[6]  D J Brooks,et al.  Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[8]  W. J. Lorenz,et al.  Performance evaluation of the whole-body PET scanner ECAT EXACT HR + , 1997 .

[9]  G Brix,et al.  Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  Guy Marchal,et al.  Multimodality image registration by maximization of mutual information , 1997, IEEE Transactions on Medical Imaging.

[11]  R B Banati,et al.  PK (‘peripheral benzodiazepine’) – binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK 11195 binding to activated microglia , 1997, Journal of neurocytology.

[12]  Gerald Q. Maguire,et al.  Comparison and evaluation of retrospective intermodality brain image registration techniques. , 1997, Journal of computer assisted tomography.

[13]  F E Turkheimer,et al.  [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen’s encephalitis , 1999, Neurology.

[14]  J. Logan Graphical analysis of PET data applied to reversible and irreversible tracers. , 1999, Nuclear medicine and biology.

[15]  R B Banati,et al.  Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK11195 , 2000, Neurology.

[16]  R B Banati,et al.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.

[17]  R Tomczak,et al.  In vivo imaging of activated microglia using [11 C]PK11195 and positron emission tomography in patients after ischemic stroke , 2000, Neuroreport.

[18]  Roger N Gunn,et al.  In-vivo measurement of activated microglia in dementia , 2001, The Lancet.

[19]  R B Banati,et al.  In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. , 2001, Brain : a journal of neurology.

[20]  Ronald Boellaard,et al.  Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET , 2001, European Journal of Nuclear Medicine.

[21]  R B Banati,et al.  Imaging cerebral vasculitis in refractory epilepsy using [(11)C](R)-PK11195 positron emission tomography. , 2001, AJR. American journal of roentgenology.

[22]  S. Gunn,et al.  Positron Emission Tomography Compartmental Models , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  R. Myers,et al.  Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury , 2001, Neuroreport.

[24]  Eric Achten,et al.  Semiquantification of the peripheral-type benzodiazepine ligand [11C]PK11195 in normal human brain and application in multiple sclerosis patients. , 2002, Acta neurologica Belgica.

[25]  O. Isacson,et al.  Neuroinflammation of the nigrostriatal pathway during progressive 6‐OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging , 2002, The European journal of neuroscience.

[26]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[27]  R B Banati,et al.  [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy , 2003, Neurology.

[28]  Eric Achten,et al.  Assessment of Neuroinflammation and Microglial Activation in Alzheimer’s Disease with Radiolabelled PK11195 and Single Photon Emission Computed Tomography , 2003, European Neurology.

[29]  J Versijpt,et al.  PET visualization of microglia in multiple sclerosis patients using [11C]PK11195 , 2003, European journal of neurology.

[30]  Tom Misteli,et al.  In vivo imaging. , 2003, Methods.

[31]  G. Glatting,et al.  Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration , 2004, Movement disorders : official journal of the Movement Disorder Society.

[32]  Elizabeth L Sampson,et al.  In vivo detection of microglial activation in frontotemporal dementia , 2004, Annals of neurology.

[33]  Alexander Gerhard,et al.  In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in corticobasal degeneration , 2004, Movement disorders : official journal of the Movement Disorder Society.

[34]  F. Turkheimer,et al.  Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study , 2004, Neurobiology of Disease.

[35]  S. Wisniewski,et al.  PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS. , 2004, The Journal of clinical investigation.

[36]  E. Yoshikawa,et al.  Microglial activation and dopamine terminal loss in early Parkinson's disease , 2005, Annals of neurology.

[37]  Alexander Gerhard,et al.  Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study , 2005, NeuroImage.

[38]  Ronald Boellaard,et al.  Development of a Tracer Kinetic Plasma Input Model for (R)-[11C]PK11195 Brain Studies , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  R B Banati,et al.  Mills’ and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[40]  J. Korf,et al.  Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study , 2005, Multiple sclerosis.

[41]  Alexander Gerhard,et al.  In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in progressive supranuclear palsy , 2006, Movement disorders : official journal of the Movement Disorder Society.